RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/35659337http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/35659337http://www.w3.org/2000/01/rdf-schema#comment"Immunoregulatory B cells impede antitumor immunity through unknown features and mechanisms. We report the existence of leucine-tRNA-synthase-2 (LARS2)-expressing B cell (LARS B) subset with a transforming growth factor-β1 (TGF-β1)-dominant regulatory feature in both mouse and human progressive colorectal cancer (CRC). Of note, LARS B cells exhibited a leucine nutrient preference and displayed active mitochondrial aminoacyl-tRNA biosynthesis. They were located outside the tertiary lymphoid structure and correlated with colorectal hyperplasia and shortened survival in CRC patients. A leucine diet induced LARS B cell generation, whereas LARS B cell deletion by Lars2 gene ablation or leucine blockage repressed CRC immunoevasion. Mechanistically, LARS2 programmed mitochondrial nicotinamide adenine dinucleotide (NAD+) regeneration and oxidative metabolism, thus determining the regulatory feature of LARS B cells in which the NAD-dependent protein deacetylase sirtuin-1 (SIRT1) was involved. We propose a leucine-dieting scheme to inhibit LARS B cells, which is safe and useful for CRC therapy."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.org/dc/terms/identifier"doi:10.1016/j.immuni.2022.04.017"xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Gu J."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Lin S."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Liu J."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Liu R."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Lu Z."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Wang Z."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Wang L."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Yu H."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Xie Z."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Xia J."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Xing Y."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Zhang D."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Zhou P."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Chu Y."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Zhao P."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Wen H."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Zhong Z."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Qian J."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Luo F."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Jiao M."xsd:string
http://purl.uniprot.org/citations/35659337http://purl.uniprot.org/core/author"Qie J."xsd:string